A novel nonpsychotropic cannabinoid, HU-211, in the treatment of experimental pneumococcal meningitis

Journal of Infectious Diseases

Volumn 173, Issue 3, 1996, Pages 735-738

  Bass, Roman ^a   Engelhard, Dan ^a   Trembovler, Victoria ^a   Shohami, Esther ^a,b  

^a HEBREW UNIVERSITY   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; CEFTRIAXONE; DEXANABINOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL MENINGITIS; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN INJURY; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOCOCCUS PNEUMONIAE;

EID: 0030041950     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.3.735     Document Type: Article

References (5)

1. Wenger JD, Hightower W, Facklam RR, Gaventa S, Broome CV, Bacterial Meningitis Study Group. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. J Infect Dis 1990;162:1316-23.
2. Dodge PR. Neurological sequelae of acute bacterial meningitis. Pediatr Ann 1994;23:101-6.
3. Quagliarello VJ, Scheld WM. Bacterial meningitis: pathogenesis, pathophysiology and progress. N Engl J Med 1992;327:864-72.
4. Guerra-Romero L, Tureen JH, Fournier MA, Makrides V, Tauber MG. Amino acids in cerebrospinal and brain interstitial fluid in experimental pneumococcal meningitis. Pediatr Res 1993;33:510-3.
5. Perry VL, Young RSK, Aquila WJ, During MJ. Effect of experimental Escherichia coli meningitis on concentrations of excitatory and inhibitory amino acids in the rabbit brain: in vivo microdialysis study. Pediatr Res 1993;34:187-91.